Prokarium gets funding from SynbiCITE to develop chlamydia vaccine
3 August 2015 | By Victoria White
Prokarium has received new funding from SynbiCITE that will enable it to complete preclinical development of an innovative chlamydia vaccine...
List view / Grid view
3 August 2015 | By Victoria White
Prokarium has received new funding from SynbiCITE that will enable it to complete preclinical development of an innovative chlamydia vaccine...
3 August 2015 | By Victoria White
AstraZeneca and Isis Pharmaceuticals are to collaborate to discover and develop antisense therapies for cardiovascular, metabolic and renal diseases...
31 July 2015 | By Oxford Global
In the run up to our 2nd Annual Drug Discovery USA Congress 2015, we spoke with Matthew Wagoner a discovery safety specialist from AstraZeneca, a confirmed speaker at the congress where he will talk about Bromodomain And ExtraTerminal (BET) Domain Inhibitors Induce A Loss Of Intestinal Stem Cells And Villous…
31 July 2015 | By Victoria White
Researchers have identified a new mechanism that the tumour suppressor protein p53 uses to trigger cell death via apoptosis...
31 July 2015 | By Victoria White
Researchers have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina...
31 July 2015 | By Victoria White
Researchers identify a pair of master regulators that control the fate of follicular helper T (TFH) cells - a finding that could improve vaccine design...
30 July 2015 | By Victoria White
Researchers have engineered a tethered ribosome that may enable the production of new drugs and next-generation biomaterials...
30 July 2015 | By Victoria White
Administration of IL-35 to mice with type 1 diabetes reverses or cures the disease by maintaining a normal blood glucose level and immune tolerance...
30 July 2015 | By Victoria White
Inovio’s DNA-based monoclonal antibody (dMAb) targeting dengue virus provided protection against a lethal dengue virus challenge in mice...
30 July 2015 | By Victoria White
Sygnature Discovery has delivered CORT125134, a glucocorticoid receptor antagonist in development for the treatment of Cushing’s syndrome, to Corcept...
29 July 2015 | By Victoria White
Scientists have precisely modifed human T cells using the CRISPR genome-editing system- a breakthrough that could lead to CRISPR/Cas9-based therapies...
29 July 2015 | By Victoria White
CF microbes are able to survive in saliva and mucus that is chemically heterogeneous, including significant portions that are largely devoid of oxygen...
29 July 2015 | By Victoria White
A two-step regimen of experimental vaccines against Middle East respiratory syndrome (MERS) prompted immune responses in mice and rhesus macaques...
29 July 2015 | By Victoria White
An international team of scientists have succeeded in decoding the molecular characteristics of an as yet incurable subtype of leukaemia...
28 July 2015 | By Victoria White
Researchers have discovered a completely new type of mycovirus that can infect the fungus Aspergillus fumigatus, which can cause the disease aspergillosis